FCHS MAY 28th DEADLINE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against First Choice Healthcare Solutions, Inc.; Investors with Losses in Excess of $100K are Encouraged to Contact the Firm – FCHS

World News: . []

NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of First Choice Healthcare Solutions, Inc. (OTC: FCHS) from April 1, 2014 through November 14, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for First Choice investors under the federal securities laws.

To join the First Choice class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email or for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants retained Elite Stock Research, Inc. to falsely promote First Choice securities to investors in order to materially inflate the price of First Choice stock; (2) Christian Romandetti, Sr., First Choice’s former CEO, President, and Chairman of the Board of Directors, participated in a scheme to materially inflate the price of First Choice securities through an unlawful, paid promotional campaign, in which Romandetti personally profited; (3) defendants were in violation of First Choice’s internal compliance policies including its Compliance Program, Code of Ethics, and Disclosure Policy, by participating in the pump and dump scheme; and (4) a primary cause of fluctuations in First Choice’s stock price was the unlawful campaign, in which Romandetti directly participated, that caused the price of First Choice stock to be inflated while at the same time allowed others to dump their First Choice stock for profit. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 28, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at or .

Follow us for updates on LinkedIn: , on Twitter: or on Facebook: .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.

-------------------------------

Contact Information:      Laurence Rosen, Esq.       Phillip Kim, Esq.       The Rosen Law Firm, P.A.       275 Madison Avenue, 34 Floor       New York, NY  10016       Tel: (212) 686-1060       Toll Free: (866) 767-3653       Fax: (212) 202-3827                          

More news and information about The Rosen Law Firm PA

Published By:

Globe Newswire: 22:38 GMT Friday 17th May 2019

Published: .

Search for other references to "fchs" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us